» Articles » PMID: 35565289

Malignant Superficial Mesenchymal Tumors in Children

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 May 14
PMID 35565289
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant superficial mesenchymal tumors are a very diverse group of neoplasms with few clinical and radiological discriminatory factors. Hence, some of these cancers are rarely suspected based on clinical and radiological grounds, others may be easily misdiagnosed, and the histological analysis of a biopsy or resection is central in the diagnostic process. In children, the age at presentation is a major element of the differential diagnosis. Some tumors have a very distinct epidemiology, while others may be seen at any age. More recently, the advances in molecular biology have greatly improved the diagnosis of mesenchymal tumors and new entities are still being described. In the present review, we provide an overview of the diversity of malignant superficial mesenchymal tumors in children, including new and/or rare entities. We discuss the important diagnostic features, be they clinical, histological, or molecular. Special attention was given to the genetic features of these tumors, particularly when they were helpful for the diagnosis or treatment.

References
1.
Miettinen M, Wang Z . Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol. 2011; 36(3):351-9. PMC: 3288441. DOI: 10.1097/PAS.0b013e318236c312. View

2.
Lopez-Nunez O, Alaggio R, John I, Ciolfi A, Pedace L, Mastronuzzi A . Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Pineal Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA Methylation Profiling. Cancers (Basel). 2021; 13(4). PMC: 7916108. DOI: 10.3390/cancers13040706. View

3.
Shulman D, Dubois S . The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers. Paediatr Drugs. 2020; 22(2):189-197. DOI: 10.1007/s40272-020-00380-9. View

4.
Drolet B, Trenor 3rd C, Brandao L, Chiu Y, Chun R, Dasgupta R . Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013; 163(1):285-91. DOI: 10.1016/j.jpeds.2013.03.080. View

5.
Tallegas M, Fraitag S, Binet A, Orbach D, Jourdain A, Reynaud S . Novel KHDRBS1-NTRK3 rearrangement in a congenital pediatric CD34-positive skin tumor: a case report. Virchows Arch. 2018; 474(1):111-115. DOI: 10.1007/s00428-018-2415-0. View